Europe Microtome Market Growth Opportunities and Forecast by 2027

Europe microtome market is expected to reach US$ 58,738.7 thousand in 2027 from US$ 38,985.9 thousand in 2019. The market is predicted to grow with a CAGR of 5.4% from 2020-2027.

 

The growth of the market is driven by factors such as the rising prevalence of cancer and the increasing adoption of digital pathology in developed economies. However, the Europe Microtome market is likely to have a negative impact due to lack of skilled professionals.

Cancer is among the significant reasons of death globally, and its increasing prevalence is boosting the number of histopathology tests. A tissue pathology analysis is needed for the examination of a malignant tumour to predict the onset of cancer. As per the data from the Global Cancer Observatory (WHO), the expected 446,942 cancers were diagnosed in 2018 in the UK. Moreover, approximately 178,473 cancer deaths were recorded among the population in 2018 in the country. Similarly, in Germany, 608,742 cancers were diagnosed in 2018.

Furthermore, about 247 462 cancer deaths were recorded among the population in 2018 in Germany. Increasing rates of cancer and growing knowledge concerning early diagnostic procedures are expected to boost the adoption rate of microtomes throughout the forecast period. Examination of biopsy tissues helps pathologists in discovering cancer type, stage, and the degree of disease spread.

Moreover, increasing awareness programs initiated by organizations such as the Cancer Research UK, the German Cancer Society, the National Health Service (NHS), and the German Cancer Research Center for cancer screening are further propelling the market growth. For instance, the National Health Service (NHS) intends cervical screening programs for all women among 25 and 64 years of age in the UK. The factors mentioned above are expected to drive the growth of the market for microtome during the coming years.

Moreover, the impact of the COVID-19 pandemic on the microtome market is severe. Hospital and clinical laboratories are engaged in handling COVID-19 patients, which has halted the diagnosis of other diseases. Moreover, the focus has been shifted to find a cure for the virus, which has suspended all the other research activities in the region. For instance, EFPIA member companies are engaged in finding vaccines, diagnostics, and treatments for the outbreak. At present, there are more than 100 vaccine candidates in development and over 600 clinical trials underway to find a remedy against COVID-19 globally.

Europe Microtome Market Revenue and Forecast to 2027 (US$ Mn)

Europe Microtome Market– Market Segmentation

By Product

• Microtome Instruments
  • Rotary Microtomes
  • Cryostat Microtomes
  • Vibrating Microtomes
  • Other Microtome Instruments
• Microtome Accessories

By Technology

• Manual Microtomes
• Semi-automated Microtomes
• Fully Automated Microtomes

By End User

• Hospitals
• Clinical Laboratories
• Other End Users

By Country

• UK
• Germany
• France
• Italy
• Spain

Company Profiles

• PHC Holdings Corporation
• MEDITE Medical GmbH
• Leica Biosystems Nussloch GmbH (Danaher)
• Histo-Line Laboratories
• SLEE medical GmbH

Europe Microtome Report Scope